Article Menu

Export Article

More by Authors Links

Article Data

  • Views 2553
  • Dowloads 160

Case Reports

Open Access

Dermatomyositis in the course of primary peritoneal cancer

  • A. Lewandowska-Graduszewska1,*,
  • J. Markowska2

1,Department of Anaesthesiology and Intensive Therapy at the Clinical Hospital of Lord's Transfiguration in Poznań

2Department of Oncological Gynecology, Chair and Clinic of Oncology, Medical University of Poznań (Poland)

DOI: 10.12892/ejgo5210.2019 Vol.40,Issue 6,December 2019 pp.1055-1056

Published: 10 December 2019

*Corresponding Author(s): A. Lewandowska-Graduszewska E-mail: jmarkomed@poczta.onet.pl

PDF (105.67 kB) View Full-text

Abstract

Dermatomyositis (DM) is a rare paraneoplastic syndrome. The case of a 47-year-old woman who was hospitalized in a neurological clinic due to non-specific neurological and dermatological symptoms is described. The results of laboratory tests (including CA 125 > 2,000 U/ml), histopathology and imaging, as well as the lack of response to treatment with steroids and methotrexate were indicative of DM in the course of malignancy. Diagnosis of primary peritoneal cancer was established on the basis of reconnaissance laparoscopy. Due to the significant weakening of muscle strength, weakening of cough reflex and swallowing disorders on the second day after surgery, the patient underwent a percutaneous tracheostomy. As a result of causative treatment with cytostatics (carboplatin with pacli-taxel), paraneoplastic symptoms receded. The patient is currently in remission.

Keywords

Paraneoplastic syndromes; Dermatomyositis; Peritoneal cancer.

Cite and Share

A. Lewandowska-graduszewska, J. Markowska. Dermatomyositis in the course of primary peritoneal cancer. European Journal of Gynaecological Oncology. 2019; 40(6): 1055-1056. doi: 10.12892/ejgo5210.2019

URL:

https://www.ejgo.net/articles/10.12892/ejgo5210.2019

References

[1] Pelosof L.C., Gerber D.E.: “Paraneoplastic syndromes: an approach to diagnosis and treatment”. Mayo Clinic Proc., 2010, 85(9), 838.

[2] Szczeklik A.: “Internal diseases”, Practical Medicine (First Ed.), 2006, 2, 1678.

[3] Ofori E., Ramai D., Ona M., Reddy M.: “Paraneoplastic Dermato-myositis Syndrome Presenting as Dysphagia”, Gastroenterology Res., 2017, 10, 251.

[4] Requena C., Alfaro A., Traves V., Nagore E., Llombart B., Serra C., et al.: “Paraneoplastic dermatomyositis: a study of 12 cases”. Actas Dermosif., 2014, 105, 675.

[5] Eranki VG.: “A Recurrent Episode of Dermatomyositis Associated with Papillary Thyroid Cancer”, Case Reports in Endocrinol., 2017, 2017, 7985953.

[6] Vilchez-Marquez F., Prieto-Llamas R., Sanchez-Sanchez G.: “Der-matomyositis associated with ovarian cancer”. Med. Clin., 2017, 148, e55, .

[7] Levine D., Miller S., Al-Dawsari N., Barak O., Gottlieb A.B.: “Para-neoplastic dermatoses associated with gynecologic and breast ma-lignancies”. Obstet. Gynecol. Surv., 2010, 65, 455.

[8] Arshad I., Barton D.: “Dermatomyositis as a paraneoplastic phe-nomen in ovarian cancer”. BMJ Case Rep., 2016, doi;10.1136/bcr-2016-215463.

[9] Viau M., Renaud MC., Gregoire J., Sebastianelli A., Plante M.: “Paraneoplastic syndromes associated with gynecological cancers: A systematic review”. Gynecol.Oncol., 2017, 146, 661.

[10] Ben-Zwi N., Shani A., Ben-Baruch G., Agmon-Levin N., Sthoeger Z., Huszar M., et al.: “Dermatomyositis following the diagnosis of ovarian cancer”. Int. J Gynecol Cancer, 2005, 15, 1124.

Submission Turnaround Time

Top